Cargando…
Therapy of Subclinical Mastitis during Lactation
This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868077/ https://www.ncbi.nlm.nih.gov/pubmed/35203812 http://dx.doi.org/10.3390/antibiotics11020209 |
_version_ | 1784656177846550528 |
---|---|
author | McDougall, Scott Clausen, Laura M. Hussein, Hassan M. Compton, Chris W. R. |
author_facet | McDougall, Scott Clausen, Laura M. Hussein, Hassan M. Compton, Chris W. R. |
author_sort | McDougall, Scott |
collection | PubMed |
description | This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells/mL) that had an intramammary infection were randomly assigned at cow level to no treatment (Control; n = 80 glands), intramammary infusion of 200 mg cloxacillin sodium on three occasions at 48 h intervals (3 × 48 h; n = 273 glands), five occasions at 24 h intervals (5 × 24 h; n = 279 glands), or on five occasions at 48 h intervals (5 × 48 h; n = 72 glands). Glands were resampled at 21 (±3) and 28 (±3) days after initiation of treatment. The gland-level cure rate for any pathogen was 5/80 (6.2%), 139/173 (49.8%), 172/297 (61.6%) and 58/72 (80.6%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. The cure rate for major pathogens (defined as Staphylococcus aureus or Streptococcus spp.) was 4/52 (7.7%), 84/197 (42.6%), 96/183 (52.5%) and 36/48 (75%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. We conclude that treatment was superior to no treatment, and bacteriological cure rate was higher with the 5 × 24 h protocol than for the 3 × 48 h protocol and was higher with the 5 × 48 h than the 5 × 24 h protocol. |
format | Online Article Text |
id | pubmed-8868077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88680772022-02-25 Therapy of Subclinical Mastitis during Lactation McDougall, Scott Clausen, Laura M. Hussein, Hassan M. Compton, Chris W. R. Antibiotics (Basel) Article This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells/mL) that had an intramammary infection were randomly assigned at cow level to no treatment (Control; n = 80 glands), intramammary infusion of 200 mg cloxacillin sodium on three occasions at 48 h intervals (3 × 48 h; n = 273 glands), five occasions at 24 h intervals (5 × 24 h; n = 279 glands), or on five occasions at 48 h intervals (5 × 48 h; n = 72 glands). Glands were resampled at 21 (±3) and 28 (±3) days after initiation of treatment. The gland-level cure rate for any pathogen was 5/80 (6.2%), 139/173 (49.8%), 172/297 (61.6%) and 58/72 (80.6%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. The cure rate for major pathogens (defined as Staphylococcus aureus or Streptococcus spp.) was 4/52 (7.7%), 84/197 (42.6%), 96/183 (52.5%) and 36/48 (75%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. We conclude that treatment was superior to no treatment, and bacteriological cure rate was higher with the 5 × 24 h protocol than for the 3 × 48 h protocol and was higher with the 5 × 48 h than the 5 × 24 h protocol. MDPI 2022-02-07 /pmc/articles/PMC8868077/ /pubmed/35203812 http://dx.doi.org/10.3390/antibiotics11020209 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article McDougall, Scott Clausen, Laura M. Hussein, Hassan M. Compton, Chris W. R. Therapy of Subclinical Mastitis during Lactation |
title | Therapy of Subclinical Mastitis during Lactation |
title_full | Therapy of Subclinical Mastitis during Lactation |
title_fullStr | Therapy of Subclinical Mastitis during Lactation |
title_full_unstemmed | Therapy of Subclinical Mastitis during Lactation |
title_short | Therapy of Subclinical Mastitis during Lactation |
title_sort | therapy of subclinical mastitis during lactation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868077/ https://www.ncbi.nlm.nih.gov/pubmed/35203812 http://dx.doi.org/10.3390/antibiotics11020209 |
work_keys_str_mv | AT mcdougallscott therapyofsubclinicalmastitisduringlactation AT clausenlauram therapyofsubclinicalmastitisduringlactation AT husseinhassanm therapyofsubclinicalmastitisduringlactation AT comptonchriswr therapyofsubclinicalmastitisduringlactation |